The Latest on Veeva’s Antitrust Lawsuit Against IQVIA
Life sciences companies should have the freedom to choose the software and data products that meet their business needs without restriction. Choice is good for the market and beneficial for customers.
Veeva and IQVIA have software and data products that compete. IQVIA prevents customers from loading IQVIA data products into certain Veeva software products including Network, Nitro and other Veeva software products. We believe IQVIA’s anti-competitive actions harm the industry by raising costs, limiting choice, and slowing innovation, which is ultimately bad for patients.
In March 2017, after three years of trying to find an amicable resolution, Veeva filed a lawsuit against IQVIA to end the long history of anti-competitive behavior and eliminate unfair data restrictions for the life sciences industry.
Current status
- Discovery is closed and a trial date has been set for February 2025. However, the scope of trial has not been finalized and we expect a ruling on that topic soon.
- We are confident in our case and believe we will win, but there is no guarantee.
What happens if Veeva wins?
- A favorable ruling would serve as a precedent that would deter IQVIA from being abusive with their TPA policies in the future.
What happens if IQVIA wins?
- Things could remain as they are today unless further customer pressure can convince IQVIA to change their behavior.
What should customers do?
- Voice concerns to the IQVIA management team, including the IQVIA CEO, as the IQVIA CEO is the decision maker on this matter.
- Don’t give IQVIA new business if they continue with current policies that harm the industry.
- Consider alternative suppliers for existing IQVIA business over time.
IQVIA issued a misleading press release on May 10, 2021 about a recent procedural ruling in the lawsuit. What does that mean and what is Veeva’s response?
We will keep this page up to date so that you always have the latest information on the status.
See the timeline
| Early 2007 |
Veeva founded; launches Veeva CRM
|
| 2007 to 2014 |
IMS and Cegedim sign TPAs to allow customers to use IMS reference data and Cegedim OneKey in Veeva CRM |
| Early 2014 |
Veeva launches Veeva Network (MDM) and OpenData (customer reference data) |
| Early 2014 |
Cegedim signs TPAs to allow customers to use Cegedim OneKey in Veeva Network |
| Mid 2014 |
IMS refuses to sign TPAs to allow use of IMS reference data in Veeva Network |
| Mid 2014 |
IMS announces acquisition of Cegedim |
| Late 2014 |
Cegedim changes policy, refuses to sign TPA for use of Cegedim OneKey in Veeva Network |
| Mid 2015 |
IMS acquisition of Cegedim is finalized |
| Mid 2016 |
IMS merges with Quintiles to form Quintiles IMS, later changes name to IQVIA |
| Fall 2016 |
Veeva exhausts all avenues for negotiated resolution, decides to prepare for a lawsuit |
| Jan 2017 |
IQVIA files a “trade secret” lawsuit claiming Veeva is stealing IQVIA customer reference data. We believe this lawsuit was filed to justify and protect their anticompetitive behavior |
| March 2017 |
Veeva sues IQVIA for violations of federal and state antitrust laws arising from, among other things, IQVIA’s refusal to allow customers to load certain IQVIA data to the Veeva Network (MDM) solution |
| Mid 2018 |
Veeva announces Veeva Nitro (data warehouse built on Amazon Redshift) |
| Mid 2018 |
IQVIA restricts use of customer reference data in Veeva Nitro |
| Late 2018 |
Judge rules against IQVIA motion to dismiss, ruling that all Veeva antitrust claims can proceed (judge’s opinion can be found here) |
| July 2019 |
Veeva files additional lawsuit against IQVIA for violations of federal and state antitrust laws arising from, among other things, IQVIA’s refusal to allow customers to load certain IQVIA data to the Veeva Nitro (data warehouse) solution |
| Feb 2020 |
Veeva files amended lawsuit complaint to address IQVIA’s expanding abusive behavior (e.g., blocking use of IQVIA data in Veeva Andi for AI) and to address IQVIA’s unauthorized access to Veeva applications |
| Early 2024 |
Discovery is closed |
| Feb 2025 |
Expected trial date for the lawsuit and expected TPA relief if IQVIA is found to have violated antitrust laws |